Repository logo
 
Publication

Inhibition of pancreatic α-amylase activity by a group of hydroxyxanthones

dc.contributor.authorSantos, Clementina M.M.
dc.contributor.authorProença, Carina
dc.contributor.authorFreitas, Marisa
dc.contributor.authorAraújo, Alberto N.
dc.contributor.authorSilva, Artur
dc.contributor.authorFernandes, Eduarda
dc.date.accessioned2022-08-02T14:09:15Z
dc.date.available2022-08-02T14:09:15Z
dc.date.issued2020
dc.description.abstractDiabetes mellitus is a non-infectious and non-transmissible life threatening disease. It is one of the fastest growing health challenges of the current century, in which the number of adults living with diabetes have more than tripled over the past 20 years. According to the International Diabetes Federation, 1 in 11 adults (20-79 years) have diabetes (463 million people) and 2 in 3 people with diabetes live in urban areas.1 This may be closely related to genetic and lifestyle factors such as physical inactivity, unhealthy diets, obesity, raised blood cholesterol and glucose, stress, etc.2 Diabetes mellitus is an endocrine disorder that occurs when pancreas does not produce enough insulin, when the body cannot use insulin efficiently or both situations, leading to chronic hyperglycemia. Thus, the control of postprandial blood glucose level via the inhibition of digestive enzymes, such as α-glucosidase and/or α-amylase, is a relevant strategy for the management of type 2 diabetes and its complications.3 During the last two decades, in the pursuit for novel antidiabetic drugs, a wide variety of natural and synthetic xanthone derivatives have been applied in the inhibition of α-glucosidase enzyme activity, however, the effects of this class of compounds on the activity of α-amylase enzyme is scarce.4 With this ratio in mind and as part of our on-going project, the aim of the present study is to investigate the effect of a series of hydroxyxanthones 1 on pancreatic α-amylase activity to find out the relevance of this group of compounds in controlling blood glucose levels for the treatment of disorders related with the carbohydrate uptake. Different concentrations of xanthones 1 were incubated with the enzyme and the hydrolysis of the substrate 2-chloro-p-nitrophenyl-α-D-maltotriose was monitored spectrophotometrically at 405 nm. Acarbose was used as the standard inhibitor. In addition, the study of the inhibition type was carried out through nonlinear regression Michaelis-Menton enzymatic kinetics and the corresponding Lineweaver-Burk plot.5 The results pointed out that the IC50 values obtained ranged from 23 to 90 μM, considerably higher than the values obtained for the positive control acarbose (IC50 = 0.62 ± 0.07 μM). For the active compounds, two of them revealed a competitive type of inhibition while for the remaining ones a noncompetitive type of inhibition was recorded. More details concerning the structureactivity relationship will be presented and discussed in this communication.pt_PT
dc.description.sponsorshipThis work received financial support from the European Union (FEDER funds POCI/01/0145/FEDER/007265) and National Funds (FCT/MEC, Fundação para a Ciência e Tecnologia and Ministério da Educação e Ciência) under the Partnership Agreement PT2020 UID/AGR/00690/2019; UID/QUI/50006/2019; UID/QUI/00062/2019, and “Programa Operacional Competitividade e Internacionalização” (COMPETE) (POCI-01-0145-FEDER-029241), and under the framework of QREN (NORTE-01-0145-FEDER-000024).pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationSantos, Clementina M.M.; Proença, Carina; Freitas, Marisa; Araújo, Alberto N.; Silva, Artur; Fernandes, Eduarda (2020). Inhibition of pancreatic α-amylase activity by a group of hydroxyxanthones. In 13th National Organic Chemistry Meeting. Aveiropt_PT
dc.identifier.urihttp://hdl.handle.net/10198/25797
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSociedade Portuguesa de Químicapt_PT
dc.relationMountain Research Centre
dc.relationAssociated Laboratory for Green Chemistry - Clean Technologies and Processes
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectDiabetes Mellituspt_PT
dc.titleInhibition of pancreatic α-amylase activity by a group of hydroxyxanthonespt_PT
dc.typeconference object
dspace.entity.typePublication
oaire.awardTitleMountain Research Centre
oaire.awardTitleAssociated Laboratory for Green Chemistry - Clean Technologies and Processes
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FAGR%2F00690%2F2019/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FQUI%2F50006%2F2019/PT
oaire.citation.conferencePlaceAveiropt_PT
oaire.citation.endPage66pt_PT
oaire.citation.startPage66pt_PT
oaire.citation.title13th National Organic Chemistry Meeting/6th National Medicinal Chemistry Meetingpt_PT
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
person.familyNameSantos
person.givenNameClementina M.M.
person.identifier.ciencia-id9018-DB9C-C590
person.identifier.orcid0000-0003-4380-7990
person.identifier.scopus-author-id7201458663
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typeconferenceObjectpt_PT
relation.isAuthorOfPublication64f662b6-775d-4ea0-bfd7-f527af0ac1a0
relation.isAuthorOfPublication.latestForDiscovery64f662b6-775d-4ea0-bfd7-f527af0ac1a0
relation.isProjectOfPublicationd6683ba1-d253-48e4-968e-35106ce7b750
relation.isProjectOfPublicationa8b5499f-df63-4561-a825-05c4eca80d9a
relation.isProjectOfPublication.latestForDiscoverya8b5499f-df63-4561-a825-05c4eca80d9a

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
CS - 2020 ENQT.pdf
Size:
529.9 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: